Penserra Capital Management LLC Sage Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$37.06 - $47.11 $49,845 - $63,362	-1,345 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$40.26 - $57.37 $603 - $860	15 Added 1.13%	1,345 $59,000
Q2 2021 Aug 12, 2021	BUY	$54.88 - $79.29 $548 - $792	10 Added 0.76%	1,330 $75,000
Q1 2021 May 13, 2021	BUY	$70.65 - $96.76 $8,831 - $12,095	125 Added 10.46%	1,320 $98,000
Q4 2020 Feb 12, 2021	BUY	$58.41 - $89.06 $69,799 - $106,426	1,195 New	1,195 $103,000

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.